Bassant_2000_Eur.J.Pharmacol_387_151

Reference

Title : Sustained effect of metrifonate on cerebral glucose metabolism after immunolesion of basal forebrain cholinergic neurons in rats - Bassant_2000_Eur.J.Pharmacol_387_151
Author(s) : Bassant MH , Poindessous-Jazat F , Schmidt BH
Ref : European Journal of Pharmacology , 387 :151 , 2000
Abstract :

To evaluate the influence of cholinergic projections from the basal forebrain on brain metabolism, we measured the cerebral metabolic rate of glucose (CMR(glu)) after unilateral lesioning of cholinergic basal forebrain neurons with the immunotoxin 192 IgG-saporin. CMR(glu) was determined in 24 cortical and 13 sub-cortical regions using the [14C]2-deoxy-D-glucose technique of Sokoloff. Average hemispheric CMR(glu) decreased by 7% (P<0.02) and 5% (P<0.05), 7 and 21 days after lesion, respectively. Regional effects were restricted to parietal and retrosplenial cortices, lateral habenula and the basal forebrain. We have previously shown that metrifonate increased CMR(glu) in intact rats. In lesioned rats, metrifonate (80 mg/kg, i. p.) was still active but the metabolic activation was reduced in terms of both the average hemispheric CMR(glu) and the number of regions significantly affected. Although it is reduced, the sustained effect of metrifonate in lesioned rats makes an argument for the use of this compound as treatment of cholinergic deficit in Alzheimer's disease.

PubMedSearch : Bassant_2000_Eur.J.Pharmacol_387_151
PubMedID: 10650155

Related information

Citations formats

Bassant MH, Poindessous-Jazat F, Schmidt BH (2000)
Sustained effect of metrifonate on cerebral glucose metabolism after immunolesion of basal forebrain cholinergic neurons in rats
European Journal of Pharmacology 387 :151

Bassant MH, Poindessous-Jazat F, Schmidt BH (2000)
European Journal of Pharmacology 387 :151